在用GM-CSF治疗期间可逆甲状腺功能障碍
K Hoekman1, B M von Blomberg-van der Flier, J Wagstaff
1Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
Lancet (London, England)
|August 31, 1991
概括
颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF) 可能会在患有先前存在的甲状腺抗体的患者中引发甲状腺功能障碍. 这种影响是暂时的,在停止转基因-CSF治疗后消失.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 对甲状腺抗原的自身免疫可以使癌症治疗复杂化.
- 颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF) 用于癌症治疗.
- 转基因-CSF对甲状腺自身免疫力的影响需要研究.
研究的目的:
- 为了确定GM-CSF是否诱导或加剧甲状腺自身免疫.
- 在GM-CSF治疗期间评估甲状腺功能和自身抗体状态.
主要方法:
- 研究了14名晚期乳腺癌和11名软组织肉瘤患者.
- 静脉注射多克索鲁比,环胺和GM-CSF. 静脉注射多克索鲁比,环胺和GM-CSF.
- 在治疗前和治疗期间监测甲状腺功能和自身抗体.
主要成果:
- 两名患有先前存在的甲状腺抗体的患者出现过渡性甲状腺功能障碍.
- 甲状腺功能障碍在GM-CSF停止后得到解决.
- 没有观察到新的自身免疫异常.
结论:
- 在易受影响的个体中,GM-CSF可能会暂时加剧甲状腺自身免疫.
- 通过GM-CSF的抗原呈现细胞刺激可以解释这种现象.
- 需要进一步的研究来了解GM-CSF的免疫调节作用.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...


